Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy
IntroductionSYNGR4 is considered to be one of the causative genes for amyotrophic lateral sclerosis, but its role in breast cancer development has not been revealed.MethodsThe expression of SYNGR4 in a variety of malignancies including breast cancer was analyzed using Genotype Tissue Expression (GTE...
Saved in:
Main Authors: | Jie Ma, Hongtao Wang, Zhengwei Gui, Yuanrong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1490073/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overexpression of metalloproteinase PAPPA accelerates cancer progression and correlates with immune cell infiltration in gastric cancer: insights from bioinformatics and in vitro investigations
by: Shiya Yu, et al.
Published: (2025-02-01) -
Novel pyroptosis-immune-related lncRNA signature exhibits a distinct immune cell infiltration landscape in breast cancer
by: Dedi Kong, et al.
Published: (2025-01-01) -
Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy
by: Xiaojie Liang, et al.
Published: (2025-01-01) -
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
by: Wang Caixia, et al.
Published: (2025-01-01) -
The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer
by: Yi Zhao, et al.
Published: (2025-01-01)